These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 8617869

  • 1. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.
    Gilles JG, Desqueper B, Lenk H, Vermylen J, Saint-Remy JM.
    J Clin Invest; 1996 Mar 15; 97(6):1382-8. PubMed ID: 8617869
    [Abstract] [Full Text] [Related]

  • 2. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y, Shima M, Tanaka I, Fukuda K, Yoshida K, Yoshioka A.
    Haematologica; 2004 Jun 15; 89(6):696-703. PubMed ID: 15194537
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP.
    Thromb Haemost; 2001 Dec 15; 86(6):1345-52. PubMed ID: 11776297
    [Abstract] [Full Text] [Related]

  • 5. Role of anti-idiotypic antibodies in immune tolerance induction.
    Gilles JG.
    Haemophilia; 2010 May 15; 16(102):80-3. PubMed ID: 20536989
    [Abstract] [Full Text] [Related]

  • 6. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P, Plamenová I, Hollý P, Stasko J.
    Med Sci Monit; 2009 Jun 15; 15(6):CS105-11. PubMed ID: 19488019
    [Abstract] [Full Text] [Related]

  • 7. Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapy.
    Scandella D, Reyes H, Felch M, Sakurai Y.
    Haematologica; 2000 Oct 15; 85(10 Suppl):86-8. PubMed ID: 11187882
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A.
    van Helden PM, van den Berg HM, Gouw SC, Kaijen PH, Zuurveld MG, Mauser-Bunschoten EP, Aalberse RC, Vidarsson G, Voorberg J.
    Br J Haematol; 2008 Aug 15; 142(4):644-52. PubMed ID: 18510679
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S, Ghods R, Bahrami ZS, Roohi A, Jeddi-Tehrani M, Conti-Fine BM, Sharifian RA, Rabbani H, Shokri F.
    Hum Antibodies; 2003 Aug 15; 12(3):67-76. PubMed ID: 14646035
    [Abstract] [Full Text] [Related]

  • 14. Long-term persistence of anti-factor VIII antibody-secreting cells in hemophilic mice after treatment with human factor VIII.
    Hausl C, Maier E, Schwarz HP, Ahmad RU, Turecek PL, Dorner F, Reipert BM.
    Thromb Haemost; 2002 May 15; 87(5):840-5. PubMed ID: 12038787
    [Abstract] [Full Text] [Related]

  • 15. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG, Velloso-Rodrigues C, Moreau V, Nguyen C, Villard S, Belisário AR, Granier C, Santoro MM.
    Br J Haematol; 2008 May 15; 141(5):708-15. PubMed ID: 18422780
    [Abstract] [Full Text] [Related]

  • 16. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
    Gilles JG, Peerlinck K, Arnout J, Vermylen J, Saint-Remy JM.
    Thromb Haemost; 1997 May 15; 77(5):938-43. PubMed ID: 9184406
    [Abstract] [Full Text] [Related]

  • 17. Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries.
    Schmidt A, Brettschneider K, Kahle J, Orlowski A, Becker-Peters K, Stichel D, Schulze J, Braner M, Tampé R, Schwabe D, Königs C.
    Thromb Haemost; 2016 Jul 04; 116(1):32-41. PubMed ID: 27009573
    [Abstract] [Full Text] [Related]

  • 18. Catalytic activity of antibodies against factor VIII in patients with hemophilia A.
    Lacroix-Desmazes S, Moreau A, Sooryanarayana, Bonnemain C, Stieltjes N, Pashov A, Sultan Y, Hoebeke J, Kazatchkine MD, Kaveri SV.
    Nat Med; 1999 Sep 04; 5(9):1044-7. PubMed ID: 10470082
    [Abstract] [Full Text] [Related]

  • 19. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
    Qadura M, Waters B, Burnett E, Chegeni R, Hough C, Othman M, Lillicrap D.
    Haemophilia; 2011 Mar 04; 17(2):288-95. PubMed ID: 21091850
    [Abstract] [Full Text] [Related]

  • 20. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F, Gharagozlou S, Sharifian RA, Kazemnejad A, Esmailzadeh K, Managhchi MR, Shokri F.
    Acta Haematol; 2005 Mar 04; 114(2):84-90. PubMed ID: 16103630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.